martin traebert
Novartis (Switzerland)
Basel, Switzerland
Review Editor
Pharmacology of Ion Channels and Channelopathies
Novartis (Switzerland)
Basel, Switzerland
Review Editor
Pharmacology of Ion Channels and Channelopathies
University at Albany
Albany, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
The University of Iowa
Iowa City, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
University of Genoa
Genoa, Italy
Review Editor
Pharmacology of Ion Channels and Channelopathies
University of Poitiers
Poitiers, France
Review Editor
Pharmacology of Ion Channels and Channelopathies
Institute of Biomedical Sciences, Faculty of Medicine, University of Chile
Santiago, Chile
Review Editor
Pharmacology of Ion Channels and Channelopathies
University of Oxford
Oxford, United Kingdom
Review Editor
Pharmacology of Ion Channels and Channelopathies
McGill University
Montreal, Canada
Review Editor
Pharmacology of Ion Channels and Channelopathies
University of Tennessee Health Science Center (UTHSC)
Memphis, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
The University of Texas Health Science Center at San Antonio
San Antonio, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
KU Leuven
Leuven, Belgium
Review Editor
Pharmacology of Ion Channels and Channelopathies
University College London
London, United Kingdom
Review Editor
Pharmacology of Ion Channels and Channelopathies
Spanish National Research Council (CSIC)
Madrid, Spain
Review Editor
Pharmacology of Ion Channels and Channelopathies
UMR5075 Institut de Biologie Structurale (IBS)
Grenoble, France
Review Editor
Pharmacology of Ion Channels and Channelopathies
KU Leuven
Leuven, Belgium
Review Editor
Pharmacology of Ion Channels and Channelopathies
University of California, Davis
Davis, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies